ATLANTA, Dec. 21, 2021 /PRNewswire/ — Sharecare (Nasdaq: SHCR), the digital health company that helps people manage all their health in one place, today announced that its chairman and CEO, Jeff Arnold, will present at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, Jan. 12, 2022 at 2:15 p.m. EST.
A live audio webcast and replay of the event will be available online at https://investors.sharecare.com/news-and-events/events-and-presentations.
About Sharecare
Sharecare is the leading digital health company that helps people – no matter where they are in their health journey – unify and manage all their health in one place. Our comprehensive and data-driven virtual health platform is designed to help people, providers, employers, health plans, government organizations, and communities optimize individual and population-wide well-being by driving positive behavior change. Driven by our philosophy that we are all together better, at Sharecare, we are committed to supporting each individual through the lens of their personal health and making high-quality care more accessible and affordable for everyone. To learn more, visit www.sharecare.com.
Media Relations:
Jen Martin Hall
jen@sharecare.com
Investor Relations:
Evan Smith, CFA
evan.smith@sharecare.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/sharecare-to-present-at-40th-annual-jp-morgan-healthcare-conference-301448812.html
SOURCE Sharecare
TAMPA, FL / ACCESS Newswire / December 26, 2025 / Key TakeawaysWhat it claims: Nerve…
Integrated smart technology builds on TempraMed's proven VIVI platform, providing robust Temperature control with medication…
NORTHAMPTON, MA / ACCESS Newswire / December 26, 2025 / Specialized nutrition experts are key…
"Despite clear congressional mandates and FDA authorization, the Drug Enforcement Administration failed to act within…
WASHINGTON, Dec. 26, 2025 /PRNewswire/ -- Over the past decade, China has evolved from a biotechnology…
SEATTLE, WA / ACCESS Newswire / December 26, 2025 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a…